Yu Zhang, MD
Urology · Roanoke, VANPI 1487158119
Payments from drug & device makers
What this record shows
This record is dominated by grants: $30,000 of the $33,805 with a category attached, or 88.7%. Boston Scientific accounts for 90.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $30,431 and has fallen 95.6% since, to $1,332 in 2025. Among urology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $1056.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$30K
- Procept Biorobotics Corporation$2K
- Intuitive Surgical$1K
- Laborie Medical Technologies Corp.$152
- Axonics, Inc.$134
- Pfizer$112
- plus $151 from 3 others
What the payments were for
- Grants$30,00089%
- Travel & lodging$1,6695%
- Food & beverage$2,1366%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $30,488 |
| Procept Biorobotics Corporation | 11 | $1,736 |
| Intuitive Surgical | 6 | $1,031 |
| Laborie Medical Technologies Corp. | 2 | $152 |
| Axonics, Inc. | 1 | $134 |
| Pfizer | 1 | $112 |
| Merck | 1 | $108 |
| Calyxo, Inc. | 1 | $23 |
| W. L. Gore & Associates, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,805 in reported general payments places this provider in the 90th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 12 | $5,383 |
| Tamsulosin Hcl | 196 | $2,874 |
| Finasteride | 60 | $831 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 21 | $670 |
| Cefdinir | 17 | $277 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $101 |
| Ciprofloxacin Hcl | 28 | $95 |
| Cephalexin | 21 | $61 |
Paid to pharmacies, not to this prescriber.
Other urology in Roanoke
- Charles DanielRoanoke$94K
- David KageyRoanoke$90K
- Rodney PoffenbergerRoanoke$85K
- Robert WhisnantRoanoke$84K
- Mark SchmidtRoanoke$84K
- Michael FabrizioVirginia Beach$1.5M
- Gregg EureVirginia Beach$1.4M
- Jessica DelongVirginia Beach$578K
- Robert GivenVirginia Beach$157K
- Michael WilliamsVirginia Beach$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.